<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN">
<html>

<!-- Mirrored from www.naturesbounty.com/vf/healthnotes/HN_Live/Spanish/Es-Concern/Cystic_Fibrosis.ref.htm by HTTrack Website Copier/3.x [XR&CO'2005], Thu, 03 Mar 2005 14:30:37 GMT -->
<head>
<meta http-equiv="Content-Type" content="text/html; charset=ISO-8859-1">
<meta name="Language" content="es">
<meta name="ContentID" content="1199008">
<meta name="Category" content="Concern">
<meta name="Article" content="Cystic_Fibrosis">
<title>Fibrosis Qu&#237;stica-Referencias</title>
<link type="text/css" rel="stylesheet" href="../Styles/hnqrHtml.css">
<base target="_self">
</head>
<body>
<div id="Article-Title" class="Article-Title"><a name="Article-Title"></a> 

<p class="Article-Title">Fibrosis Qu&#237;stica</p>
</div>

<div id="Reference-List" class="Reference-List">
<p class="Reference-Autofill"><a href="Cystic_Fibrosis.htm">Volver al
art&#237;culo.</a></p>

<h3>Referencias para el art&#237;culo</h3>

<ol class="Reference-List">
<li class="Ref">Wilson DC, Pencharz PB. Nutrition and cystic fibrosis. <em>Nutrition</em>
1998;14:792&#8211;5 [review].</li>

<li class="Ref">Turck D, Michaud L. Cystic fibrosis: nutritional consequences and management.
<em>Baillieres Clin Gastroenterol</em> 1998;12:805&#8211;22 [review].</li>

<li class="Ref">Schneiderman-Walker J, Pollock SL, Corey M, et al. A randomized controlled
trial of a 3-year home exercise program in cystic fibrosis. <em>J Pediatr</em>
2000;136:304&#8211;10.</li>

<li class="Ref">Littlewood JM, Wolfe SP. Control of malabsorption in cystic fibrosis. <em>
Paediatr Drugs</em> 2000;2:205&#8211;22.</li>

<li class="Ref">Borowitz DS, Grand RJ, Durie PR. Use of pancreatic enzyme supplements for
patients with cystic fibrosis in the context of fibrosing colonopathy. Consensus committee.
<em>J Pediatr</em> 1995;127:681&#8211;4.</li>

<li class="Ref">Vyas H, Matthew DJ, Milla PJ. A comparison of enteric coated microspheres with
enteric coated tablet pancreatic enzyme preparations in cystic fibrosis. A controlled study.
<em>Eur J Pediatr</em> 1990;149:241&#8211;3.</li>

<li class="Ref">Taylor CJ, Hillel PG, Ghosal S, et al. Gastric emptying and intestinal transit
of pancreatic enzyme supplements in cystic fibrosis. <em>Arch Dis Child</em>
1999;80:149&#8211;52.</li>

<li class="Ref">Darling PB, Lepage G, Leroy C, et al. Effect of taurine supplements on fat
absorption in cystic fibrosis. <em>Pediatr Res</em> 1985;19:578&#8211;82.</li>

<li class="Ref">Belli DC, Levy E, Darling PB, et al. Taurine improves the absorption of a fat
meal in patients with cystic fibrosis. <em>Pediatrics</em> 1987;80:517&#8211;23.</li>

<li class="Ref">Thompson GN, Robb TA, Davidson GP. Taurine supplementation, fat absorption,
and growth in cystic fibrosis. <em>J Pediatr</em> 1987;111:501&#8211;6.</li>

<li class="Ref">Darling PB, Lepage G, Leroy C, et al. Effect of taurine supplements on fat
absorption in cystic fibrosis. <em>Pediatr Res</em> 1985;19:578&#8211;82.</li>

<li class="Ref">Chase HP, Dupont J. Abnormal levels of prostaglandins and fatty acids in blood
of children with cystic fibrosis. <em>Lancet</em> 1978;2:236&#8211;8.</li>

<li class="Ref">Rosenlund ML, Selekman JA, Kim HK, Kritchevsky D. Dietary essential fatty
acids in cystic fibrosis. <em>Pediatrics</em> 1977;59:428&#8211;32.</li>

<li class="Ref">Lloyd-Still JD, Simon SH, Wessel HU, Gibson LE. Intravenous linoleic acid
supplementation in children with cystic fibrosis. <em>Pediatrics</em> 1979;64:50&#8211;2.</li>

<li class="Ref">Chase HP, Dupont J. Abnormal levels of prostaglandins and fatty acids in blood
of children with cystic fibrosis. <em>Lancet</em> 1978;2:236&#8211;8.</li>

<li class="Ref">Lawrence R, Sorrell T. Eicosapentaenoic acid in cystic fibrosis: evidence of a
pathogenic role for leukotriene B4. <em>Lancet</em> 1993;342:465&#8211;9.</li>

<li class="Ref">Lawrence R, Sorrell T. Eicosapentaenoic acid in cystic fibrosis: evidence of a
pathogenic role for leukotriene B4. <em>Lancet</em> 1993;342:465&#8211;9.</li>

<li class="Ref">Turck D, Michaud L. Cystic fibrosis: nutritional consequences and management.
<em>Baillieres Clin Gastroenterol</em> 1998;12:805&#8211;22 [review].</li>

<li class="Ref">Lindemans J, Neijens HJ, Kerrebijn KF, Abels J. Vitamin B12 absorption in
cystic fibrosis. <em>Acta Paediatr Scand</em> 1984;73:537&#8211;40.</li>

<li class="Ref">Gueant JL, Vidailhet M, Pasquet C, et al. Effect of pancreatic extracts on the
faecal excretion and on the serum concentration of cobalamin and cobalamin analogues in cystic
fibrosis. <em>Clin Chim Acta</em> 1984;137:33&#8211;41.</li>

<li class="Ref">Krebs NF, Sontag M, Accurso FJ, Hambidge KM. Low plasma zinc concentrations in
young infants with cystic fibrosis. <em>J Pediatr</em> 1998;133:761&#8211;4.</li>

<li class="Ref">Hansen RC, Lemen R, Revsin B. Cystic fibrosis manifesting with acrodermatitis
enteropathica-like eruption. <em>Arch Dermatol</em> 1983;119:51&#8211;5.</li>

<li class="Ref">Berezin S, Dhole A, Mascia A, Newman LJ. Small intestinal bacterial overgrowth
may impair the nutritional stature of children with cystic fibrosis. <em>Fed Proc</em>
1985;44:1858 [abstract].</li>
</ol>
</div>
</body>

<!-- Mirrored from www.naturesbounty.com/vf/healthnotes/HN_Live/Spanish/Es-Concern/Cystic_Fibrosis.ref.htm by HTTrack Website Copier/3.x [XR&CO'2005], Thu, 03 Mar 2005 14:30:37 GMT -->
</html>

